Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Safety and Effectiveness of PEG-Intron in HIV-Infected Patients

ClinicalTrials.gov ID: NCT00005012

Public ClinicalTrials.gov record NCT00005012. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 4:54 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Antiviral Activity and Tolerability of PEG-Intron in HIV-Infected Subjects Failing HAART

Study identification

NCT ID
NCT00005012
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Schering-Plough
Industry
Enrollment
250 participants

Conditions and interventions

Conditions

Interventions

  • Peginterferon alfa-2b Drug

Drug

Eligibility (public fields only)

Age range
0 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 29, 2000
Primary completion
Not listed
Completion
Aug 31, 2000
Last update posted
Jun 23, 2005

2000

United States locations

U.S. sites
21
U.S. states
14
U.S. cities
19
Facility City State ZIP Site status
East Bay AIDS Ctr Berkeley California 94705
Georgetown Univ Med Ctr Washington D.C. District of Columbia 20007
Dupont Circle Physicians Group Washington D.C. District of Columbia 200091104
IDC Research Initiative Altamonte Springs Florida 32701
Duval County Health Department Jacksonville Florida 32206
Univ of Miami School of Medicine Miami Florida 33136
Infectious Diseases Associates Sarasota Florida 34239
Piedmont Physicians at Vinings Atlanta Georgia 30339
TRIAD Health Practice Chicago Illinois 60657
Univ of Maryland Institute of Human Virology Baltimore Maryland 212011192
New England Med Ctr / Div of Geo Med & Infect Disease Boston Massachusetts 02111
Regions Hosp Saint Paul Minnesota 55101
Washington Univ St Louis Missouri 63110
Southwestern New Jersey AIDS Clinical Trials Camden New Jersey 08103
East Orange Veterans Administration Med Ctr East Orange New Jersey 07018
Beth Israel Med Ctr New York New York 10003
Univ Hosps of Cleveland Cleveland Ohio 44106
MCP Hahnemann Univ Philadelphia Pennsylvania 19102
Philadelphia FIGHT Philadelphia Pennsylvania 19107
Amelia Ct Clinic Dallas Texas 75235
Joseph C Gathe Houston Texas 77004

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00005012, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 23, 2005 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00005012 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →